Health & Beauty Singapore Exchange-Listed Singapore eDevelopment Limited’s U.S. Biomedical Subsidiary Global BioLife, Inc. Develops Low Glycemic Modified SugarBy Marie JonesMay 31, 20180 SINGAPORE – (ACN Newswire) – Singapore Exchange-listed Singapore eDevelopment Limited (“SeD”) announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. (“Global BioLife”),…
